Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 101-110 of 110 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Early mortality in a multinational systemic sclerosis inception cohortHao, Y.; Hudson, M.; Baron, M.; Carreira, P.; Stevens, W.; Rabusa, C.; Tatibouet, S.; Carmona, L.; Joven, B.; Huq, M.; Proudman, S.; Nikpour, M.
2015Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug useProudman, S.; James, M.; Spargo, L.; Metcalf, R.; Sullivan, T.; Rischmueller, M.; Flabouris, K.; Wechalekar, M.; Lee, A.; Cleland, L.
2014Cardiac arrhythmias and conduction defects in systemic sclerosisVacca, A.; Meune, C.; Gordon, J.; Chung, L.; Proudman, S.; Assassi, S.; Nikpour, M.; Rodriguez-Reyna, T.; Khanna, D.; Lafyatis, R.; Matucci-Cerinic, M.; Distler, O.; Allanore, Y.
2016Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolCalderone, A.; Stevens, W.; Prior, D.; Nandurkar, H.; Gabbay, E.; Proudman, S.; Williams, T.; Celermajer, D.; Sahhar, J.; Wong, P.; Thakkar, V.; Dwyer, N.; Wrobel, J.; Chin, W.; Liew, D.; Staples, M.; Buchbinder, R.; Nikpour, M.
2017Antifibrillarin antibodies are associated with native north American ethnicity and poorer survival in systemic sclerosisOtero, C.; Assassi, S.; Hudson, M.; Mayes, M.; Estrada-Y-Martin, R.; Pedroza, C.; Mills, T.; Walker, J.; Baron, M.; Stevens, W.; Proudman, S.; Nikpour, M.; Mehra, S.; Wang, M.; Fritzler, M.
2017A treat-to-target strategy preserves work capacity in a rheumatoid arthritis inception cohort treated with combination conventional DMARD therapyWechalekar, M.; Quinn, S.; Lester, S.; Metcalf, R.; Shanahan, E.; Walker, J.; Smith, M.; Hill, C.; Shanahan, E.; Proudman, S.
2017Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosisMorrisroe, K.; Stevens, W.; Huq, M.; Sahhar, J.; Ngian, G.; Zochling, J.; Roddy, J.; Proudman, S.; Nikpour, M.; Rischmueller, M.; ustralian Scleroderma Interest Group (ASIG),
2017Measures of disease status in systemic sclerosis: a systematic reviewTay, T.; Ferdowsi, N.; Baron, M.; Stevens, W.; Hudson, M.; Proudman, S.; Nikpour, M.; Damage Index Working Group of the Scleroderma Clinical Trials Consortium,
2017Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosisMorrisroe, K.; Stevens, W.; Huq, M.; Sahhar, J.; Ngian, G.S.; Zochling, J.; Roddy, J.; Proudman, S.; Nikpour, M.; Hill, C.; Lester, S.; Nash, P.; Rischmueller, M.; Strickland, G.; Thakkar, V.; Walker, J.
2016Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort studyMorrisroe, K.; Huq, M.; Stevens, W.; Rabusa, C.; Proudman, S.; Nikpour, M.; The Australian Scleroderma Interest Group (ASIG),